Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Significance: Trafficking of T cells to tumors is critical for the success of immunotherapy. The success against solid cancers is not as effective as desired owing to limited efficacy in delivering a higher frequency of T cells to the tumor microenvironment. At this time, no useful methods are available to enhance T-cell infiltration in tumors in a short time. New methods that could enhance T-cell trafficking in tumors are urgently in need. Up to now, the role of platelets in limiting T-cell infiltration in tumors is a neglected phenomenon. In our study, for the first time, we proved that perfluorocarbon nanoparticles could promote intratumoral infiltration of T cells via platelet inhibition, resulting in enhanced anti–PD-L1 immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“However, it is disappointing that only a subset of patients positively respond to these therapies, whereas the majority of patients show resistance to PD-L1 blockade (3).”
BackgroundCombination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294 · cited 1×
“Nowadays, it has become one of the standard antitumor therapies for patients with cancer (2).”
BackgroundJackson, H. J., Rafiq, S., & Brentjens, R. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.36 · Cited by 613
Meng, L., Cheng, Y., Gan, S., Zhang, Z., Tong, X., Xu, L., Jiang, X., Zhu, Y., Wu, J., Yuan, A., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00808 · Cited by 69 · cited 1×
“It is well known that albumin-based nanoparticles have been widely used in the clinic, like Abraxane (28).”
BackgroundSelf-citation
Cited by
Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757
Lymphatic PD-L1 expression restricts tumor-specific CD8+ T-cell responses
Cousin, N., Cap, S., Dihr, M., Tacconi, C., Detmar, M., & Dieterich, L. C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0633 · Cited by 95
“34 Zhou, Z. et al. Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 116, 11972-11977, doi:10.1073/pnas.1901987116 (2019). 35 Torcellan, T.”
InfluentialLiu, X., Ye, N., Liu, S., Guan, J., Deng, Q., Zhang, Z., Xiao, C., Ding, Z., Zhang, B., Chen, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202100233 · Cited by 83
Self-citationPhotosynthetic Microorganisms Coupled Photodynamic Therapy for Enhanced Antitumor Immune Effect
Wang, H., Liu, H., Guo, Y., Zai, W., Li, X., Xiong, W., Zhao, X., Yao, Y., Hu, Y., Zou, Z., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.10.028 · Cited by 46
Self-citation
Metadata
- Authors
- Zhou, Z., Zhang, B., Zai, W., Kang, L., Yuan, A., Hu, Y., & Wu, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2019-05-29
- Volume
- 116
- Issue
- 24
- Pages
- 11972-11977
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2946931018
- Cited by
- 82
- References
- 4
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy. https://app.cochat.ai/papers/10.1073/pnas.1901987116
- The paper
- Zhou, Z., Zhang, B., Zai, W., Kang, L., Yuan, A., Hu, Y., & Wu, J. (2019). Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1901987116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.